Condition: Uncontrolled Hypertension · Sponsor: Retension Pharmaceuticals. Inc.
The goal of this clinical trial is to learn if the drug RT-001 works to reduce high blood pressure (hypertension) in adults. It will also learn about the safety of RTN-001. The main questions it aims to answer are: Does RTN-001 lower blood pressure in patients who have uncontrolled hypertension? What medical problems do participants have when taking RTN-001? Researchers will compare RTN-001 to a placebo (a look-alike substance that contains no drug) to see if RTN-001 works to treat uncontrolled hypertension. Participants will: Take RTN-001 or a placebo every day for 12 weeks Visit the clinic about once every 2 weeks for checkups and tests Keep a diary of their symptoms and all medications that they take including RTN-001
This description comes directly from the study's public registry record.
Medical Information Information · 7036242024 · info@retensionpharmaceuticals.com
Bill CMO, PhD · 609-651-3773 · info@retensionpharmaceuticals.com
Always discuss trial participation with your own doctor first.
| Retension Clinical Site | Tucson, Arizona, United States | Recruiting |
| Retension Clinical Site | San Jose, California, United States | Recruiting |
| Retension Clinical Site | West Hills, California, United States | Recruiting |
| Retension Clinical Site | Waterbury, Connecticut, United States | Recruiting |
| Retension Clinical Site | Orlando, Florida, United States | Recruiting |
| Retension Clinical Site | Port Orange, Florida, United States | Recruiting |
| Retension Clinical Site | Tampa, Florida, United States | Recruiting |
| Retension Clinical Site | Lawrenceville, Georgia, United States | Recruiting |
| Retension Clinical Site | Peachtree Corners, Georgia, United States | Recruiting |
| Retension Clincial Site | Boston, Massachusetts, United States | Recruiting |
| Retension Clinical Site | Las Vegas, Nevada, United States | Recruiting |
| Retension Clinical Site | Las Vegas, Nevada, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07142356